Milowsky MI - Search Results

1

Phase 1/2 multiple ascending dose trial of the prostate-specific membrane antigen-targeted antibody drug conjugate MLN2704 in metastatic castration-resistant prostate cancer.

Milowsky MI, Galsky MD, Morris MJ, Crona DJ, George DJ, Dreicer R, Tse K, Petruck J, Webb IJ, Bander NH, Nanus DM, Scher HI. Milowsky MI, et al. Urol Oncol. 2016 Dec;34(12):530.e15-530.e21. doi: 10.1016/j.urolonc.2016.07.005. Epub 2016 Oct 17. Urol Oncol. 2016. PMID: 27765518 Free PMC article. Clinical Trial.

2

Neutral endopeptidase inhibits neuropeptide-mediated transactivation of the insulin-like growth factor receptor-Akt cell survival pathway.

Sumitomo M, Milowsky MI, Shen R, Navarro D, Dai J, Asano T, Hayakawa M, Nanus DM. Sumitomo M, et al. Among authors: milowsky mi. Cancer Res. 2001 Apr 15;61(8):3294-8. Cancer Res. 2001. PMID: 11309283

3

Active chemotherapy for collecting duct carcinoma of the kidney: a case report and review of the literature.

Milowsky MI, Rosmarin A, Tickoo SK, Papanicolaou N, Nanus DM. Milowsky MI, et al. Cancer. 2002 Jan 1;94(1):111-6. doi: 10.1002/cncr.10204. Cancer. 2002. PMID: 11815966 Free article. Review.

4

Advanced renal cell carcinoma.

Milowsky MI, Nanus DM. Milowsky MI, et al. Curr Treat Options Oncol. 2001 Oct;2(5):437-45. doi: 10.1007/s11864-001-0049-x. Curr Treat Options Oncol. 2001. PMID: 12057107 Review.

5

Estramustine plus a taxane for advanced prostate cancer: the new standard therapy?

Milowsky MI, Nanus DM. Milowsky MI, et al. Cancer Invest. 2002;20(5-6):849-50. doi: 10.1081/cnv-120002499. Cancer Invest. 2002. PMID: 12197243 No abstract available.

6

The utility of monoclonal antibodies in the imaging of prostate cancer.

Yao D, Trabulsi EJ, Kostakoglu L, Vallabhajosula S, Joyce MA, Nanus DM, Milowsky M, Liu H, Goldsmith SJ. Yao D, et al. Semin Urol Oncol. 2002 Aug;20(3):211-8. doi: 10.1053/suro.2002.36250. Semin Urol Oncol. 2002. PMID: 12215974 Review.

7

Phase I trial of interferon alpha2b and liposome-encapsulated all-trans retinoic acid in the treatment of patients with advanced renal cell carcinoma.

Goldberg JS, Vargas M, Rosmarin AS, Milowsky MI, Papanicoloau N, Gudas LJ, Shelton G, Feit K, Petrylak D, Nanus DM. Goldberg JS, et al. Among authors: milowsky mi. Cancer. 2002 Sep 15;95(6):1220-7. doi: 10.1002/cncr.10809. Cancer. 2002. PMID: 12216088 Free article. Clinical Trial.

8

Detection of the p110 beta subunit of phosphatidylinositol 3-kinase complexed with neutral endopeptidase.

Shen R, Milowsky MI, Ozaki N, Navarro D, Sumitomo M, Xu Y, Nanus DM. Shen R, et al. Among authors: milowsky mi. Anticancer Res. 2002 Sep-Oct;22(5):2533-8. Anticancer Res. 2002. PMID: 12529960

9

Chemotherapeutic strategies for renal cell carcinoma.

Milowsky MI, Nanus DM. Milowsky MI, et al. Urol Clin North Am. 2003 Aug;30(3):601-9, x. doi: 10.1016/s0094-0143(03)00031-4. Urol Clin North Am. 2003. PMID: 12953758 Review.

10

Targeting metastatic prostate cancer with radiolabeled monoclonal antibody J591 to the extracellular domain of prostate specific membrane antigen.

Bander NH, Trabulsi EJ, Kostakoglu L, Yao D, Vallabhajosula S, Smith-Jones P, Joyce MA, Milowsky M, Nanus DM, Goldsmith SJ. Bander NH, et al. J Urol. 2003 Nov;170(5):1717-21. doi: 10.1097/01.ju.0000091655.77601.0c. J Urol. 2003. PMID: 14532761 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

224 results

Search Page

Filters